SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing a sharp price crash and a massive liquidation event, igniting intense debate among investors who are either panic-selling due to fears of further declines or aggressively buying the dip, viewing the volatility as a manipulated opportunity before a strong recovery.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending after reporting blockbuster earnings and incredibly strong forward guidance, igniting community excitement over its future potential in the AI-driven data center market and leaving short sellers facing significant pressure.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is a top discussion point following its strong earnings report, which highlighted record iPhone and services revenue, robust growth in China, and an AI partnership with Google. Despite these stellar results, market observers are actively debating the stock's unexpectedly flat price action and the potential impact of rising memory chip costs on future profitability.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amidst a widespread crypto market downturn and significant liquidations, sparking intense community debate between optimistic buyers viewing dips as opportunities and vocal critics calling it a "scam." The narrative is further shaped by ongoing legislative developments concerning the "Clarity Act," which recently passed a committee vote with bipartisan opposition and awaits further high-level discussions.

TechCreate Group Ltd. is a holding company, which engages in the provision of technology consultancy and software solutions. The firm also offers payment, cybersecurity, and digital services. Its business areas consist of professional services, software and maintenance licenses, and hardware solutions. The company was founded by Lim Heng Hai, Lau Kok Fong and Ronald Vong in 2015 and is headquartered in Singapore.

TechCreate Group Ltd. - Ordinary Shares - Class A

TechCreate Group Ltd. (TCGL) is trending after a massive, parabolic price surge into triple digits, which the community largely attributes to a low-float short squeeze following its recent IPO, despite the company reporting no new material information to explain the extreme price action.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending amidst sharp price declines and fervent community discussions accusing entities like Binance and China of market manipulation. Despite widespread bearish sentiment and comparisons to surging gold and silver, many highlight increasing institutional staking and new AI-driven integrations on the network as strong long-term fundamentals, with ongoing debates around regulatory clarity also driving conversation.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is trending amidst a broad crypto market downturn, with active community debate over its valuation as an Ethereum proxy and frustration concerning recent price drops and management's past market predictions. Investors are closely watching for developments in crypto regulation, particularly the "Clarity Act," and institutional interest in Ethereum, which contrast with current market weakness.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending amidst a notable price dip that has broken key technical support levels, creating a split among investors who view it as either a prime buying opportunity before upcoming earnings or a justified correction of its high valuation. Controversial government contracts, particularly with ICE, alongside a new partnership with Innodata, are fueling highly polarized community discussions about the company's ethics and future trajectory.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending with intense debate among investors anticipating its upcoming earnings report, as many expect a significant beat and potential S&P 500 inclusion, while others remain wary of past dilutions and the stock's historical tendency to sell off even on good news.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as CEO Ryan Cohen's public comments about pursuing a major acquisition with the company's substantial cash reserve ignite fervent community speculation on potential targets, fueling intense debate between bullish investors and skeptical short sellers.

statis crypto Watchlist

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Crescent Biopharma (NASDAQ:CBIO) Upgraded by Guggenheim to Strong-Buy Rating

Guggenheim upgraded Crescent Biopharma to a "strong-buy" rating and set a $35.00 price objective for the company in a research note on Wednesday...

Crescent Biopharma (NASDAQ:CBIO) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened

Crescent Biopharma (NASDAQ:CBIO) Share Price Crosses Above 200 Day Moving Average - Here's Why...

Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Brokerages

Shares of Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) have been given a consensus recommendation of "Buy" by the seven brokerages that are currently covering the company, MarketBeat.com...

Braidwell LP Invests $4.22 Million in Crescent Biopharma, Inc. $CBIO

Braidwell LP acquired a new stake in Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange...

BVF Inc. IL Makes New Investment in Crescent Biopharma, Inc. $CBIO

BVF Inc. IL purchased a new stake in Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and...

Fairmount Funds Management Llc Purchases 1,360,000 Shares of Crescent Biopharma (NASDAQ:CBIO) Stock

Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) Director Fairmount Funds Management Llc bought 1,360,000 shares of the stock in a transaction on Thursday, December 4th. The shares were...

Crescent Biopharma (NASDAQ:CBIO) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen downgraded shares of Crescent Biopharma from a "hold" rating to a "sell" rating in a research report on Saturday...

<ul class="summary-bullets"><li>Crescent Biopharma is partnering with the Chinese firm Kelun-Biotech to expand its oncology drug pipeline and accelerate its combination strategy.&nbsp;</li><li>The company also announced a $185 million private placement, expected to close around December 8.</li><li>Stocktwits retail sentiment for the stock was ‘extremely bullish’.</li></ul><a href="https://stocktwits.com/symbol/CBIO">Crescent Biopharma (CBIO)</a> announced a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co. to expand its pipeline of oncology drugs and speed up its combination strategy. The company also announced a $185 million private placement, expected to close around December 8.Shares of Crescent were up over 40% in pre-market trading.The company said it has three distinct programs that are expected to enter the clinic in 2026. In addition, the private financing will boost its cash runway.“We’re excited to share the tremendous progress we’ve made executing on our strategy of building a robust portfolio of next-generation oncology therapeutics," said Joshua Brumm, chief executive officer of Crescent.<h2 class="st-heading-2">Partnership Details</h2>The deal will allow Crescent exclusive rights to research, develop, and commercialize SKB105 (also known as CR-003) in the United States, Europe, and all markets excluding Greater China. This is an integrin beta-6 (ITGB6)-directed antibody-drug conjugate (ADC) with a topoisomerase payload.Meanwhile, Kelun-Biotech will obtain exclusive rights to research, develop, and commercialize CR-001 in Greater China, including mainland China, Hong Kong, Macau, and Taiwan. The drug is Crescent’s bispecific antibody that the company says has the potential to be foundational in immuno-oncology.Both Crescent and Kelun-Biotech will retain the right to independently develop CR-001 in combination with proprietary ADC pipeline assets.“CR-001, our PD-1 x VEGF bispecific antibody, has the potential to be a foundational immuno-oncology backbone and the partnership we announced with Kelun-Biotech today has enhanced our pipeline of ADCs and accelerated our efforts to deliver potentially best-in-class novel combination therapies,” said Brumm.<h2 class="st-heading-2">Retail Reaction</h2>Stocktwits retail sentiment for the stock changed from ‘neutral’ to ‘extremely bullish’ while message volume jumped to ‘extremely high’.<img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_5_01_28_PM_png_71929a932d.webp" alt="Stocktwits retail sentiment for the stock is ‘extremely bullish’ while message volume remained ‘extremely high’."> One user noted they were ‘bullish’ on the stock, adding “In with a starter!”<stembedurl>https://stocktwits.com/KuruHabesha/message/638133096</stembedurl>Another said that the stock was long forgotten in their portfolio.<stembedurl>https://stocktwits.com/walkingprinter/message/638132752</stembedurl>Shares of Crescent Biopharma were down about 47% year-to-date but have gained almost 8% in the last month.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/why-tigr-stock-rose-premarket-trade-today/cLILDuARESm">Here’s Why TIGR Stock Rose In Premarket Today – And Retail Traders Think The Rally’s Just Starting</a>For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Researcher performing microbiology separator for PCR diagnosis test in pathology laboratory. 

The Deal That Sent Crescent Biopharma Shares Surging Over 40% Pre-Market Today

Crescent Biopharma announced a strategic partnership with the Chinese firm Sichuan Kelun-Biotech Biopharmaceutical Co. to fast-track its global oncology pipeline. 

Equity

Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Analysts

Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) has been given a consensus recommendation of "Buy" by the seven ratings firms that are currently covering the firm, Marketbeat.com reports...

Crescent Biopharma (NASDAQ:CBIO) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded Crescent Biopharma from a "sell" rating to a "hold" rating in a report on Sunday...

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

Current Price	$10.15
Prev Close	$10.73
Open	$10.67
Dividend Yield	0.00%
50-Day Moving Average	$12.67
Beta	0.61
Avg. Volume	219,682.82
PE Ratio	-0.46

52-Week High	$37.00
52-Week Low	$9.81
Market Capitalization	$295.68M
EPS (Annual)	-$58.75
Price to Book	1.25
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

CBIO
Crescent Biopharma Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest CBIO News

CBIOCrescent Biopharma Inc.